Simultaneous determination and pharmacokinetics study of valsartan, sacubitril and its major metabolite in human plasma, urine and peritoneal dialysis fluid in patients with end-stage renal disease by UPLC–MS/MS

沙库比林 缬沙坦 化学 腹膜透析 药代动力学 色谱法 代谢物 尿 活性代谢物 液相色谱-质谱法 药理学 质谱法 医学 内科学 血压 生物化学
作者
Ying Jin,Yi He,Xiangjie Di,Lisha Fu,Xiaohui Qi,Бо Лю,Li Zheng,Yongsheng Wang,Hui Zhong,Zhenlei Wang
出处
期刊:Journal of Chromatography B [Elsevier]
卷期号:1208: 123402-123402 被引量:3
标识
DOI:10.1016/j.jchromb.2022.123402
摘要

Sacubitril/valsartan was indicated for the treatment of heart failure and hypertension in patients with end-stage renal disease on peritoneal dialysis therapy. Herein, a rapid, sensitive and robust method based on ultra-liquid chromatography-tandem mass spectrometry (UPLC-MS/MS) was developed and validated for the determination of the concentrations of valsartan, sacubitril and its major metabolite LBQ657 in plasma, urine and peritoneal dialysis fluid. Samples were extracted from various biological fluids using protein precipitation. Extracts were subjected to UPLC-MS/MS with electrospray ionization in positive-ion mode. The developed method was fully validated over a concentration range of 8.00-8000 ng/mL for valsartan, 2.00-2000 ng/mL for sacubitril and 30.0-30,000 ng/mL for LBQ657 in plasma, 2.00-1000 ng/mL for valsartan, 1.00-500 ng/mL for sacubitril and 20.0-10000 ng/mL for LBQ657 in urine, and 0.200-100 ng/mL for valsartan, 0.0400-20.0 ng/mL for sacubitril and 2.00-1000 ng/mL for LBQ657 in peritoneal dialysis fluid. The intra- and inter-day precisions for all analytes in various matrices were less than 12.3%, and the intra- and inter-day accuracies results were all between 88.0% and 109.2%. All analytes were stable for at least 8 h at room temperature (25°C), five freeze-thaw cycles, and 37 days at -40°C and -80°C in plasma, urine and peritoneal dialysis fluid. In conclusion, this developed method is reliable, sensitive and specific for determining the concentrations of valsartan, sacubitril and LBQ657 in plasma, urine and peritoneal dialysis fluid. The assay was available to pilot the pharmacokinetics study of sacubitril/valsartan in patients with end-stage renal disease on peritoneal dialysis, and it could provide evidence that peritoneal dialysis had an effect on the clearance of sacubitril/valsartan.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
亚尔发布了新的文献求助10
1秒前
酷波er应助努力的咩咩采纳,获得10
1秒前
1秒前
1秒前
科研通AI2S应助太渊采纳,获得10
2秒前
一石二鸟应助科研通管家采纳,获得10
2秒前
bkagyin应助科研通管家采纳,获得10
2秒前
pluto应助科研通管家采纳,获得10
2秒前
热心的匕应助科研通管家采纳,获得10
2秒前
Fernanda完成签到,获得积分10
2秒前
2秒前
Orange应助科研通管家采纳,获得10
2秒前
2秒前
完美世界应助科研通管家采纳,获得10
2秒前
2秒前
李健应助科研通管家采纳,获得10
2秒前
星辰大海应助科研通管家采纳,获得10
2秒前
大模型应助科研通管家采纳,获得10
3秒前
3秒前
英俊的铭应助科研通管家采纳,获得10
3秒前
烟花应助科研通管家采纳,获得10
3秒前
大模型应助科研通管家采纳,获得10
3秒前
科研通AI2S应助科研通管家采纳,获得10
3秒前
田様应助科研通管家采纳,获得10
3秒前
3秒前
3秒前
3秒前
3秒前
4秒前
思垢发布了新的文献求助10
5秒前
5秒前
深情安青应助皮皮虾采纳,获得10
5秒前
5秒前
打打应助好大一点采纳,获得10
6秒前
7秒前
Patrick完成签到,获得积分10
7秒前
跳跃鸽子发布了新的文献求助10
7秒前
畅快沛白发布了新的文献求助30
8秒前
娜写年华完成签到 ,获得积分10
8秒前
NexusExplorer应助飘逸的白玉采纳,获得10
8秒前
高分求助中
Kinetics of the Esterification Between 2-[(4-hydroxybutoxy)carbonyl] Benzoic Acid with 1,4-Butanediol: Tetrabutyl Orthotitanate as Catalyst 1000
The Young builders of New china : the visit of the delegation of the WFDY to the Chinese People's Republic 1000
Rechtsphilosophie 1000
Bayesian Models of Cognition:Reverse Engineering the Mind 888
Very-high-order BVD Schemes Using β-variable THINC Method 568
Chen Hansheng: China’s Last Romantic Revolutionary 500
XAFS for Everyone 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3138062
求助须知:如何正确求助?哪些是违规求助? 2789039
关于积分的说明 7789616
捐赠科研通 2445478
什么是DOI,文献DOI怎么找? 1300354
科研通“疑难数据库(出版商)”最低求助积分说明 625902
版权声明 601046